tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geulah Livshits, 271 are a BUY (97.83%), 6 are a HOLD (2.17%).
Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 32.6% that have a potential upside of 53.04% achieved within 165 days.
Geulah Livshits’s has documented 487 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IMTX, Immatics NV at 19-May-2026.
Analyst best performing recommendations are on PDSB (PDS BIOTECHNOLOGY CORP).
The best stock recommendation documented was for PDSB (PDS BIOTECHNOLOGY CORP) at 5/20/2021. The price target of $11 was fulfilled within 7 days with a profit of $3.73 (51.31%) receiving and performance score of 73.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-May-2022
$82
$27.77 (51.21%)
$82
30 days ago
(31-Aug-2026)
9/30 (30%)
$25.02 (43.91%)
202
Buy Since 04-Mar-2021
$80
$25.77 (47.52%)
$80
30 days ago
(31-Aug-2026)
13/27 (48.15%)
$23.02 (40.40%)
167
Buy Since 18-Apr-2024
$88
$33.77 (62.27%)
$82
1 months 26 days ago
(04-Aug-2026)
12/23 (52.17%)
$34.93 (65.82%)
134
Buy Since 03-Feb-2025
$80
$25.77 (47.52%)
$80
2 months 22 days ago
(08-Jul-2026)
5/10 (50%)
$20.8 (35.14%)
82
Hold Since 11-Jun-2026
$60
$5.08 (9.25%)
$32
3 months 19 days ago
(11-Jun-2026)
8/9 (88.89%)
$9.77 (19.45%)
254
Which stock is Geulah Livshits most bullish on?
Which stock is Geulah Livshits most reserved on?
What Year was the first public recommendation made by Geulah Livshits?
